missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18561736

CCR3 Antibody (61828) [DyLight 488], Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals FAB155K

Product Code. 18561736

  • € 723.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CCR3 Monoclonal antibody specifically detects CCR3 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CCR3
Monoclonal
DyLight 488
50mM Sodium Borate
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF
61828
Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF-ready
b-chemokine receptor, CC chemokine receptor 3, C-C chemokine receptor type 3, C-C CKR-3, CCR-3, CD193 antigen, chemokine (C-C motif) receptor 3, CKR3CC-CKR-3CMKBR3CD193, eosinophil CC chemokine receptor 3, Eosinophil eotaxin receptor, MGC102841
Y3 rat myeloid cell line transfected with human CCR3, Accession # P51677
0.1 mL
Chemokines and Cytokines, Cytokine Research, GPCR, Immunology, Innate Immunity, Signal Transduction
1232
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.